Trials / Completed
CompletedNCT01941238
Incidence of Hypoglycemia During Ramadan in Patients With Type1 Diabetes on Insulin Pump Versus Multi Dose Injection
Incidence of Hypoglycemia During Ramadan in Patients With Type1 Diabetes on Insulin Pump Versus Multi-dose Insulin Injection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 142 (actual)
- Sponsor
- Reem Mohammad Alamoudi · Academic / Other
- Sex
- All
- Age
- 14 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Managing patients with type1 diabetes when fasting Ramadan is very challenging. Insulin pump offers the advantage of flexibility and precision to administering insulin and has been proven to reduce severe hypoglycemia compared to multi-dose injection (MDI). However, there are extremely limited studies on the difference between insulin pump compared to MDI on the incidence of hypoglycemia and other acute complications during fasting Ramadan The investigators hypothesized that insulin pump would be associated with less hypoglycemic events during fasting Ramadan compared to MDI without deterioration in glycemic control. Results of this study are descriptive but will fill a current gap in knowledge and may contribute to development of future guidelines for the management of type1DM during Ramadan.
Conditions
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2013-09-01
- Completion
- 2014-11-01
- First posted
- 2013-09-13
- Last updated
- 2015-04-07
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT01941238. Inclusion in this directory is not an endorsement.